217 related articles for article (PubMed ID: 23143674)
1. Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interaction.
Nishimura T; Hu Y; Wu M; Pham E; Suemizu H; Elazar M; Liu M; Idilman R; Yurdaydin C; Angus P; Stedman C; Murphy B; Glenn J; Nakamura M; Nomura T; Chen Y; Zheng M; Fitch WL; Peltz G
J Pharmacol Exp Ther; 2013 Feb; 344(2):388-96. PubMed ID: 23143674
[TBL] [Abstract][Full Text] [Related]
2. Chimeric mice with humanized liver.
Katoh M; Tateno C; Yoshizato K; Yokoi T
Toxicology; 2008 Apr; 246(1):9-17. PubMed ID: 18248870
[TBL] [Abstract][Full Text] [Related]
3. Effect of hepatitis C virus infection on the mRNA expression of drug transporters and cytochrome p450 enzymes in chimeric mice with humanized liver.
Kikuchi R; McCown M; Olson P; Tateno C; Morikawa Y; Katoh Y; Bourdet DL; Monshouwer M; Fretland AJ
Drug Metab Dispos; 2010 Nov; 38(11):1954-61. PubMed ID: 20693416
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms and Predictions of Drug-Drug Interactions of the Hepatitis C Virus Three Direct-Acting Antiviral Regimen: Paritaprevir/Ritonavir, Ombitasvir, and Dasabuvir.
Shebley M; Liu J; Kavetskaia O; Sydor J; de Morais SM; Fischer V; Nijsen MJMA; Bow DAJ
Drug Metab Dispos; 2017 Jul; 45(7):755-764. PubMed ID: 28483778
[TBL] [Abstract][Full Text] [Related]
5. In vivo induction of human cytochrome P450 3A4 by rifabutin in chimeric mice with humanized liver.
Katoh M; Watanabe M; Tabata T; Sato Y; Nakajima M; Nishimura M; Naito S; Tateno C; Iwasaki K; Yoshizato K; Yokoi T
Xenobiotica; 2005 Sep; 35(9):863-75. PubMed ID: 16308281
[TBL] [Abstract][Full Text] [Related]
6. Use of transgenic mouse models to understand the oral disposition and drug-drug interaction potential of cobimetinib, a MEK inhibitor.
Choo EF; Woolsey S; DeMent K; Ly J; Messick K; Qin A; Takahashi R
Drug Metab Dispos; 2015 Jun; 43(6):864-9. PubMed ID: 25813936
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor.
Mosure KW; Knipe JO; Browning M; Arora V; Shu YZ; Phillip T; Mcphee F; Scola P; Balakrishnan A; Soars MG; Santone K; Sinz M
J Pharm Sci; 2015 Sep; 104(9):2813-23. PubMed ID: 25631585
[TBL] [Abstract][Full Text] [Related]
8. Application of chimeric mice with humanized liver for predictive ADME.
Katoh M; Yokoi T
Drug Metab Rev; 2007; 39(1):145-57. PubMed ID: 17364883
[TBL] [Abstract][Full Text] [Related]
9. Maraviroc: in vitro assessment of drug-drug interaction potential.
Hyland R; Dickins M; Collins C; Jones H; Jones B
Br J Clin Pharmacol; 2008 Oct; 66(4):498-507. PubMed ID: 18647303
[TBL] [Abstract][Full Text] [Related]
10. Casopitant: in vitro data and SimCyp simulation to predict in vivo metabolic interactions involving cytochrome P450 3A4.
Motta P; Pons N; Pagliarusco S; Pellegatti M; Bonomo F
Drug Metab Dispos; 2011 Mar; 39(3):363-72. PubMed ID: 21149541
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of P450 inhibition and induction by artemisinin antimalarials in human liver microsomes and primary human hepatocytes.
Xing J; Kirby BJ; Whittington D; Wan Y; Goodlett DR
Drug Metab Dispos; 2012 Sep; 40(9):1757-64. PubMed ID: 22679214
[TBL] [Abstract][Full Text] [Related]
12. Activation of morphine glucuronidation by fatty acyl-CoAs and its plasticity: a comparative study in humans and rodents including chimeric mice carrying human liver.
Nurrochmad A; Ishii Y; Nakanoh H; Inoue T; Horie T; Sugihara K; Ohta S; Taketomi A; Maehara Y; Yamada H
Drug Metab Pharmacokinet; 2010; 25(3):262-73. PubMed ID: 20610885
[TBL] [Abstract][Full Text] [Related]
13. Prediction of human drug-drug interactions from time-dependent inactivation of CYP3A4 in primary hepatocytes using a population-based simulator.
Xu L; Chen Y; Pan Y; Skiles GL; Shou M
Drug Metab Dispos; 2009 Dec; 37(12):2330-9. PubMed ID: 19773538
[TBL] [Abstract][Full Text] [Related]
14. Application of Static Models to Predict Midazolam Clinical Interactions in the Presence of Single or Multiple Hepatitis C Virus Drugs.
Cheng Y; Ma L; Chang SY; Humphreys WG; Li W
Drug Metab Dispos; 2016 Aug; 44(8):1372-80. PubMed ID: 27226352
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Time Dependent Inhibition Assays for Marketed Oncology Drugs: Comparison of Human Hepatocytes and Liver Microsomes in the Presence and Absence of Human Plasma.
Mao J; Tay S; Khojasteh CS; Chen Y; Hop CE; Kenny JR
Pharm Res; 2016 May; 33(5):1204-19. PubMed ID: 26869174
[TBL] [Abstract][Full Text] [Related]
16. Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam.
van Waterschoot RA; Rooswinkel RW; Sparidans RW; van Herwaarden AE; Beijnen JH; Schinkel AH
Drug Metab Dispos; 2009 Dec; 37(12):2305-13. PubMed ID: 19752211
[TBL] [Abstract][Full Text] [Related]
17. Prediction of crizotinib-midazolam interaction using the Simcyp population-based simulator: comparison of CYP3A time-dependent inhibition between human liver microsomes versus hepatocytes.
Mao J; Johnson TR; Shen Z; Yamazaki S
Drug Metab Dispos; 2013 Feb; 41(2):343-52. PubMed ID: 23129213
[TBL] [Abstract][Full Text] [Related]
18. Observation of Clinically Relevant Drug Interaction in Chimeric Mice with Humanized Livers: The Case of Valproic Acid and Carbapenem Antibiotics.
Suzuki E; Koyama K; Nakai D; Goda R; Kuga H; Chiba K
Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):965-972. PubMed ID: 28447323
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus.
Good SS; Moussa A; Zhou XJ; Pietropaolo K; Sommadossi JP
PLoS One; 2020; 15(1):e0227104. PubMed ID: 31914458
[TBL] [Abstract][Full Text] [Related]
20. In vitro phase I cytochrome P450 metabolism, permeability and pharmacokinetics of SB639, a novel histone deacetylase inhibitor in preclinical species.
Venkatesh PR; Goh E; Zeng P; New LS; Xin L; Pasha MK; Sangthongpitag K; Yeo P; Kantharaj E
Biol Pharm Bull; 2007 May; 30(5):1021-4. PubMed ID: 17473456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
